Skip to main content
. 2020 Jul 15;7:110. doi: 10.3389/fcvm.2020.00110

Table 1.

Participants' characteristics and demographics.

Participant Age Chronic disease Days recorded
DomoCare® EMFIT QS Everion® AX3
1 >90 Progressive dementia 292 157 76 97
2 >90 Heart failure 580 434 210 105
3 86–90 Heart failure 545 504 203 133
4 86–90 398 225 126 197
5 81–85 555 470 205 165
6 70–75 224 432 200 122
7 76–80 530 458 231 139
8 76-80 509 622 164 143
9 >90 422 303 242 139
10 >90 506 430 302 152
11 86–90 Insulin-dependent diabetes, recurrent urosepsis 529 332 227 116
12 >90 Heart failure, recurrent urosepsis 600 523 190 147
13 >90 438 352 155 172
14 >90 411 280 225 165
15 >90 Progressive dementia 353 313 158 147
16 76–80 Heart failure, recurrent tachycardia 358 215 215 158
17 86–90 357 211 152 118
18 >90 Progressive dementia, pulmonary embolism 555 380 157 168
19 >90 Recurrent pulmonary embolism, right heart failure 225 159 31 67
20 81–85 Bradycardia/pacemaker 458 395 194 134
21 >90 167 291 175 140
22 86–90 538 380 20 141
23 86–90 Insulin-dependent diabetes 194 54 0 0
24 86–90 Parkinson's disease, insulin-dependent diabetes 349 185 0 0